DOCSLIB.ORG

Proinflammatory Bacterial Wall Components Acid and Modulates

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Proinflammatory Bacterial Wall Components Acid and Modulates Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components This information is current as Robert Bucki, Fitzroy J. Byfield, Alina Kulakowska, of September 23, 2021. Margaret E. McCormick, Wieslaw Drozdowski, Zbigniew Namiot, Thomas Hartung and Paul A. Janmey J Immunol 2008; 181:4936-4944; ; doi: 10.4049/jimmunol.181.7.4936 http://www.jimmunol.org/content/181/7/4936 Downloaded from References This article cites 59 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/181/7/4936.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components1 Robert Bucki,2* Fitzroy J. Byfield,* Alina Kulakowska,† Margaret E. McCormick,* Wieslaw Drozdowski,† Zbigniew Namiot,‡ Thomas Hartung,§ and Paul A. Janmey* The various functions of gelsolin in extracellular compartments are not yet clearly defined but include actin scavenging and antiin- flammatory effects. Gelsolin was recently reported to bind endotoxin (LPS) from various Gram-negative bacteria with high affinity. In this study we investigate whether gelsolin also interacts with bacterial wall molecules of Gram-positive bacteria such as lipoteichoic acid (LTA) and whether gelsolin’s interaction with bacterial lipids from Gram-negative or Gram-positive bacteria affects their cellular inflammatory responses. A peptide based on the PPI binding site of gelsolin (160–169) binds purified LTA at the same molecular Downloaded from ratio that it binds phosphatidylinositol 4,5-bisphosphate. The OD of recombinant human plasma gelsolin was found to decrease following the addition of purified LTA, and the binding of gelsolin to LTA inhibits F-actin depolymerization by gelsolin. Simul- taneously, the ability of LTA to activate translocation of NF-␬B, E-selectin expression, and adhesion of neutrophils to LTA-treated human aortic endothelial cells was compromised by gelsolin. Gelsolin was able to partially inhibit LPS- or LTA-induced release of IL-8 from human neutrophils but was unable to prevent Gram-positive Bacillus subtilis or Gram-negative Pseudomonas aeruginosa growth and had no effect on the antibacterial activity of the cathelicidin-derived antibacterial peptide LL37. These data http://www.jimmunol.org/ suggest that extracellular gelsolin is involved in the host immune recognition of LTA or LPS following release of these molecules from the bacterial outer membrane during cell division or attack by drugs and immune components. The Journal of Immunology, 2008, 181: 4936–4944. elsolin is an ϳ84-kDa actin-binding protein first identi- proposed is adult respiratory distress syndrome (ARDS)3 (8). Ac- fied in the cytoplasm. Intracellular gelsolin is involved tin release in excess of the actin scavenger molecules’ capacities G in the remodeling of actin filaments associated with affects the lung because of its size and rich blood flow through cell shape changes and movement (1, 2). Cells from gelsolin- narrow vessels, leading to the characteristic inflammatory null mice exhibit a variety of motility and cytoskeletal defects. changes of ARDS. In established ARDS cases, plasma gelsolin by guest on September 23, 2021 Gelsolin-null fibroblasts have pronounced actin stress fibers, a levels were found to be on average 30% of normal values (4). phenotype consistent with an inability to sever and remodel Recently, repletion with exogenous plasma gelsolin was found actin filaments (3). The functions of extracellular gelsolin are to be beneficial in mice subjected to hyperoxia (9), a condition less well defined. Initially its involvement in scavenging F-actin that often results in ARDS development. Furthermore, the treat- polymers released into the circulation during cell death was the ment of mice with exogenous plasma gelsolin significantly only role considered (4, 5). This preventative nature of gelsolin blunted neutrophil recruitment to the lungs (9), and gelsolin was is an idea supported by observations that a reduction in plasma able to attenuate vascular permeability associated with burn in- gelsolin as well as the detection of circulating gelsolin-actin jury in rats (5). Reduction in plasma gelsolin levels was also complexes were reported in a variety of human and animal in- observed in patients with sepsis, myocardial infarction, hepati- jury states (4, 6, 7). tis, myonecrosis (10), and trauma (11, 12). However, an insuf- One of the most important clinical examples of secondary injury ficiency in the blood F-actin buffering system has not been ob- in which the pathological implication of circulating F-actin was served, and the involvement of plasma gelsolin in inflammatory mediator transport has been proposed (13). Plasma gelsolin binds LPS from various bacteria, and some LPS-induced cellular functions are neutralized by gelsolin and by *University of Pennsylvania, Institute for Medicine and Engineering, Philadelphia, PA 19104; †Department of Neurology and ‡Department of Physiology, Medical Uni- a peptide based on gelsolin residues 160–169 (14). The gelsolin P2 versity of Bialystok, Bialystok, Poland; §European Union Joint Research Centre, In- peptide (residues 150–169) binds LPS with greater affinity than it stitute for the Protection and Security of the Citizen, the Traceability, Risk and Vul- binds lysophosphatidic acid (LPA) (15), a potent extracellular ag- nerability Assessment Unit (TRiVA), Ispra, Italy; and Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany onist that influences endothelial cell migration and proliferation Received for publication October 2, 2007. Accepted for publication July 24, 2008. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance 3 Abbreviations used in this paper: ARDS, adult respiratory distress syndrome; CSF, with 18 U.S.C. Section 1734 solely to indicate this fact. cerebrospinal fluid; DLS, dynamic light scattering; HAEC, human aorta endothelial 1 cells; LBP, LPS-binding protein; LPA, lysophosphatidic acid; LTA, lipoteichoic acid; This work was supported by the National Institutes of Health (Grant AR38910), the Malp-2, macrophage-activating lipopeptide-2; MIC, minimal inhibitory concentra- Cystic Fibrosis Foundation, and the Medical University of Bialystok Grant 3-44903L. tion; PAF, platelet-activating factor; PBP10, rhodamine B-QRLFQVKGRR; PIP2, 2 Address correspondence and reprint requests to Dr. Robert Bucki, University of phosphatidylinositol 4,5-bisphosphate; RhB, rhodamine B; rhGSN, recombinant hu- Pennsylvania, Institute for Medicine and Engineering, 1010 Vagelos Research Lab- man plasma gelsolin. oratories, 3340 Smith Walk, Philadelphia, PA 19104. E-mail address: buckirob@ mail.med.upenn.edu Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00 www.jimmunol.org The Journal of Immunology 4937 (16). Plasma gelsolin was also found to interfere with platelet- (L4015), and Bacillus subtilis (L3265) were purchased from Sigma- activating factor (PAF)-induced cellular activation in vitro, sug- Aldrich. According to the manufacturer’s quality control, the preparation Ͻ gesting a protective mechanism for gelsolin in vivo (17). These of LTA contained 1 ng of LPS/1 mg of LTA, and therefore LPS would contribute Ͻ10 pg/ml culture medium in the highest LTA concentration findings suggest a new role for plasma gelsolin in inflammatory used. Purified LTA from S. aureus was prepared as described previously response and, in this context, actin may directly affect gelsolin (23, 31). To calculate molar concentrations of LPS and LTA, we have used binding to LPS, LPA, or PAF. the lowest range of their reported molecular mass in buffer without divalent LPS and lipoteichoic acid (LTA) represent the major virulence cations (stock solution was made in H2O). Recombinant human plasma gelsolin (rhGSN) was obtained from Biogen Idec. Solution of human al- factors of Gram-negative and Gram-positive bacteria, respectively. bumin was from Baxter Healthcare. Human aortic endothelial cells LTA concentrations can reach higher levels at infectious sites (HAECs) were obtained from BioWhittaker. ELISA kit for IL-8 determi- compared with LPS. Reported local tissue concentrations of LTA nation was from BioLegend. Heat-inactivated P. aeruginosa (PAO1) and can be as high as 26 ␮g/ml (18), which may be associated with the B. subtilis (American Type Culture Collection (ATCC) 6051) were ob- 8 7 ␮ tained by autoclaving their suspension (10 CFU/ml) in PBS for1hat fact
Load more

Recommended publications
  • October 2020
    PCORI Health Care Horizon Scanning System: Horizon Scanning COVID-19 Supplement Status Report Volume 1, Issue 2 Prepared for: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036 Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12 Prepared by: ECRI 5200 Butler Pike Plymouth Meeting, PA 19462 Investigators: Randy Hulshizer, MA, MS Marcus Lynch, PhD, MBA Jennifer De Lurio, MS Brian Wilkinson, MA Damian Carlson, MS Christian Cuevas, PhD Andrea Druga, MSPAS, PA-C Misha Mehta, MS Prital Patel, MPH Donna Beales, MLIS Eloise DeHaan, BS Eileen Erinoff, MSLIS Cassia Hulshizer, AS Madison Kimball, MS Maria Middleton, MPH Diane Robertson, BA Kelley Tipton, MPH Rosemary Walker, MLIS Karen Schoelles, MD, SM October 2020 Statement of Funding and Purpose This report incorporates data collected during implementation of the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System COVID-19 Supplement, operated by ECRI under contract to PCORI, Washington, DC (Contract No. MSA- HORIZSCAN-ECRI-ENG-2018.7.12). The findings and conclusions in this document are those of the authors, who are responsible for its content. No statement in this report should be construed as an official position of PCORI. An innovation that potentially meets inclusion criteria might not appear in this report simply because the horizon scanning system has not yet detected it or it does not yet meet inclusion criteria outlined in the PCORI Health Care Horizon Scanning System: Horizon Scanning Protocol and Operations Manual COVID-19 Supplement. Inclusion or absence of innovations in the horizon scanning reports will change over time as new information is collected; therefore, inclusion or absence should not be construed as either an endorsement or rejection of specific interventions.
    [Show full text]
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • Multi-Product Lactic Acid Bacteria Fermentations: a Review
    fermentation Review Multi-Product Lactic Acid Bacteria Fermentations: A Review José Aníbal Mora-Villalobos 1 ,Jéssica Montero-Zamora 1, Natalia Barboza 2,3, Carolina Rojas-Garbanzo 3, Jessie Usaga 3, Mauricio Redondo-Solano 4, Linda Schroedter 5, Agata Olszewska-Widdrat 5 and José Pablo López-Gómez 5,* 1 National Center for Biotechnological Innovations of Costa Rica (CENIBiot), National Center of High Technology (CeNAT), San Jose 1174-1200, Costa Rica; [email protected] (J.A.M.-V.); [email protected] (J.M.-Z.) 2 Food Technology Department, University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] 3 National Center for Food Science and Technology (CITA), University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] (C.R.-G.); [email protected] (J.U.) 4 Research Center in Tropical Diseases (CIET) and Food Microbiology Section, Microbiology Faculty, University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] 5 Bioengineering Department, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), 14469 Potsdam, Germany; [email protected] (L.S.); [email protected] (A.O.-W.) * Correspondence: [email protected]; Tel.: +49-(0331)-5699-857 Received: 15 December 2019; Accepted: 4 February 2020; Published: 10 February 2020 Abstract: Industrial biotechnology is a continuously expanding field focused on the application of microorganisms to produce chemicals using renewable sources as substrates. Currently, an increasing interest in new versatile processes, able to utilize a variety of substrates to obtain diverse products, can be observed.
    [Show full text]
  • Liquid Crystalline Bacterial Outer Membranes Are Critical for Antibiotic Susceptibility
    Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility Nicolò Paracinia, Luke A. Cliftonb, Maximilian W. A. Skodab, and Jeremy H. Lakeya,1 aInstitute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom; and bISIS Pulsed Neutron and Muon Source, Science and Technology Facilities Council (STFC), Rutherford Appleton Laboratory, Didcot, Oxfordshire OX11 OQX, United Kingdom Edited by Hiroshi Nikaido, University of California, Berkeley, CA, and approved June 21, 2018 (received for review March 6, 2018) The outer membrane (OM) of Gram-negative bacteria is a robust, The OM is difficult to precisely address by biophysical methods impermeable, asymmetric bilayer of outer lipopolysaccharides (LPSs) in vivo, largely because of the close proximity of the inner mem- and inner phospholipids containing selective pore proteins which brane. This has led to considerable debate concerning its structure confer on it the properties of a molecular sieve. This structure severely and dynamics (9). Although its asymmetric lipid distribution was limits the variety of antibiotic molecules effective against Gram- initially controversial, it is now widely accepted that LPS is the negative pathogens and, as antibiotic resistance has increased, so has major lipid component of the outer leaflet while phospholipids are the need to solve the OM permeability problem. Polymyxin B (PmB) confined to the periplasmic side of the membrane (1). However, represents those rare antibiotics which act directly on the OM and while plasma membranes are generally accepted to be fluid sys- which offer a distinct starting point for new antibiotic development. tems, the physical state of OM lipids remains unclear.
    [Show full text]
  • Streptococcus Response to Group B Role of Lipoteichoic Acid in The
    Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus Philipp Henneke, Siegfried Morath, Satoshi Uematsu, Stefan Weichert, Markus Pfitzenmaier, Osamu Takeuchi, Andrea This information is current as Müller, Claire Poyart, Shizuo Akira, Reinhard Berner, of September 28, 2021. Giuseppe Teti, Armin Geyer, Thomas Hartung, Patrick Trieu-Cuot, Dennis L. Kasper and Douglas T. Golenbock J Immunol 2005; 174:6449-6455; ; doi: 10.4049/jimmunol.174.10.6449 Downloaded from http://www.jimmunol.org/content/174/10/6449 References This article cites 48 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/174/10/6449.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus1 Philipp Henneke,3* Siegfried Morath,2† Satoshi Uematsu,2§ Stefan Weichert,* Markus Pfitzenmaier,‡ Osamu Takeuchi,§ Andrea Mu¨ller,* Claire Poyart,¶ Shizuo Akira,§ Reinhard Berner,* Giuseppe Teti,# Armin Geyer,‡ Thomas Hartung,† Patrick Trieu-Cuot,ʈ Dennis L.
    [Show full text]
  • The Effects of Porphyromonas Gingivalis Lipids on Atherosclerosis Formation in Mice." (2004)
    University of Connecticut OpenCommons@UConn SoDM Masters Theses School of Dental Medicine June 2004 The ffecE ts of Porphyromonas Gingivalis Lipids on Atherosclerosis Formation in Mice. Steven Robert Sierakowski Follow this and additional works at: https://opencommons.uconn.edu/sodm_masters Recommended Citation Sierakowski, Steven Robert, "The Effects of Porphyromonas Gingivalis Lipids on Atherosclerosis Formation in Mice." (2004). SoDM Masters Theses. 134. https://opencommons.uconn.edu/sodm_masters/134 IThe Effects of Porphyromonas gingivalis Lipids on Atherosclerosis Formation in Mice Steven Robert Sierakowski B.S., Villanova University, 1998 D.M.D., University of Pennsylvania, 2001 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Dental Science at the lJniversity of Connecticut 2004 APPROVAL PAGE Master of Dental Science Thesis The Effects of Porphyromonas gingivalis Lipids on Atherosclerosis Formation in Mice Presented by Steven Robert Sierakowski, B.S., D.M.D. Major Advisor Frank C. Nichols /":,1 AssociateAdvisor~~~~~_~~_~_: __~_~_~·~_·~_'~~' ~.~~:~.~~.~~.~~._.~_~~.~~~,~~_.~~~~~~~~ Arthur KHand r Associ~eAdvisor~~~~~~/~j_·~~~~~~_~~-_-_-_-_.. ~~~~~~~~~~ .~ ..,. John W. Dean, III / University of Connecticut 2004 11 To the memory of my mother, Nina, whose love will never be forgotten, And To my father, Robert, whose own academic leadership has inspired me to further my education, and whose unwavering love and support encouraged me to persevere. 111 Acknowledgments I would like to thank my major advisor, Dr. Frank Nichols, whose dedication to academic excellence created an environment conducive to learning and personal merit; and my associate advisors, Dr. Arthur Hand and Dr. John Dean, whose generous time and thoughtful suggestions are deeply appreciated.
    [Show full text]
  • Antibacterial Effects of Lactobacillus and Bacteriocin PLNC8 Αβ on The
    Khalaf et al. BMC Microbiology (2016) 16:188 DOI 10.1186/s12866-016-0810-8 RESEARCH ARTICLE Open Access Antibacterial effects of Lactobacillus and bacteriocin PLNC8 αβ on the periodontal pathogen Porphyromonas gingivalis Hazem Khalaf1* , Sravya Sowdamini Nakka1,2, Camilla Sandén3, Anna Svärd3, Kjell Hultenby4, Nikolai Scherbak5, Daniel Aili3 and Torbjörn Bengtsson1 Abstract Background: The complications in healthcare systems associated with antibiotic-resistant microorganisms have resulted in an intense search for new effective antimicrobials. Attractive substances from which novel antibiotics may be developed are the bacteriocins. These naturally occurring peptides are generally considered to be safe and efficient at eliminating pathogenic bacteria. Among specific keystone pathogens in periodontitis, Porphyromonas gingivalis is considered to be the most important pathogen in the development and progression of chronic inflammatory disease. The aim of the present study was to investigate the antimicrobial effects of different Lactobacillus species and the two-peptide bacteriocin PLNC8 αβ on P. gingivalis. Results: Growth inhibition of P. gingivalis was obtained by viable Lactobacillus and culture media from L. plantarum NC8 and 44048, but not L. brevis 30670. The two-peptide bacteriocin from L. plantarum NC8 (PLNC8 αβ) was found to be efficient against P. gingivalis through binding followed by permeabilization of the membranes, using Surface plasmon resonance analysis and DNA staining with Sytox Green. Liposomal systems were acquired to verify membrane permeabilization by PLNC8 αβ. The antimicrobial activity of PLNC8 αβ was found to be rapid (1 min) and visualized by TEM to cause cellular distortion through detachment of the outer membrane and bacterial lysis. Conclusion: Soluble or immobilized PLNC8 αβ bacteriocins may be used to prevent P.
    [Show full text]
  • Versatile Effects of Bacterium-Released Membrane Vesicles on Mammalian Cells and Infectious/ Inflammatory Diseases
    Acta Pharmacologica Sinica (2018) 39: 514–533 © 2018 CPS and SIMM All rights reserved 1671-4083/18 www.nature.com/aps Review Article Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/ inflammatory diseases You-jiang YU1, Xiao-hong WANG2, Guo-Chang FAN2, * 1Medical College of Yangzhou Polytechnic College, Yangzhou 225009, China; 2Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA Abstract Gram-negative bacterium-released outer-membrane vesicles (OMVs) and Gram-positive bacterium-released membrane vesicles (MVs) share significant similarities with mammalian cell-derived MVs eg( , microvesicles and exosomes) in terms of structure and their biological activities. Recent studies have revealed that bacterial OMVs/MVs could (1) interact with immune cells to regulate inflammatory responses, (2) transport virulence factors (eg, enzymes, DNA and small RNAs) to host cells and result in cell injury, (3) enhance barrier function by stimulating the expression of tight junction proteins in intestinal epithelial cells, (4) upregulate the expression of endothelial cell adhesion molecules, and (5) serve as natural nanocarriers for immunogenic antigens, enzyme support and drug delivery. In addition, OMVs/MVs can enter the systemic circulation and induce a variety of immunological and metabolic responses. This review highlights the recent advances in the understanding of OMV/MV biogenesis and their compositional remodeling. In addition, interactions between OMVs/MVs and various types of mammalian cells (ie, immune cells, epithelial cells, and endothelial cells) and their pathological/preventive effects on infectious/inflammatory diseases are summarized. Finally, methods for engineering OMVs/MVs and their therapeutic potential are discussed.
    [Show full text]
  • Increased Levels of Sphingosine-1-Phosphate In
    Kułakowska et al. Journal of Neuroinflammation 2014, 11:193 JOURNAL OF http://www.jneuroinflammation.com/content/11/1/193 NEUROINFLAMMATION RESEARCH Open Access Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis Alina Kułakowska1, Fitzroy J Byfield2,Małgorzata Żendzian-Piotrowska3, Joanna M Zajkowska4, Wiesław Drozdowski1, Barbara Mroczko5, Paul A Janmey2 and Robert Bucki2,6,7* Abstract Background: Tick-borne encephalitis (TBE) is a serious acute central nervous system infection that can result in death or long-term neurological dysfunctions. We hypothesize that changes in sphingosine-1-phosphate (S1P) concentration occur during TBE development. Methods: S1P and interleukin-6 (IL-6) concentrations in blood plasma and cerebrospinal fluid (CSF) were measured using HPLC and ELISA, respectively. The effects of S1P on cytoskeletal structure and IL-6 production were assessed using rat astrocyte primary cultures with and without addition of plasma gelsolin and the S1P receptor antagonist fingolimod phosphate (FTY720P). Results: We report that acute inflammation due to TBE virus infection is associated with elevated levels of S1P and IL-6 in the CSF of infected patients. This elevated concentration is observed even at the earliest neurologic stage of disease, and may be controlled by glucocorticosteroid anti-inflammatory treatment, administered to patients unresponsive to antipyretic drugs and who suffer from a fever above 39°C. In vitro, treatment of confluent rat astrocyte monolayers with a high concentration of S1P (5 μM) results in cytoskeletal actin remodeling that can be prevented by the addition of recombinant plasma gelsolin, FTY720P, or their combination. Additionally, gelsolin and FTY720P significantly decreased S1P-induced release of IL-6.
    [Show full text]
  • Lipopolysaccharide Versus Lipoteichoic Acid Leukocyte
    Profound Differences in Leukocyte-Endothelial Cell Responses to Lipopolysaccharide Versus Lipoteichoic Acid This information is current as Bryan G. Yipp, Graciela Andonegui, Christopher J. Howlett, of September 25, 2021. Stephen M. Robbins, Thomas Hartung, May Ho and Paul Kubes J Immunol 2002; 168:4650-4658; ; doi: 10.4049/jimmunol.168.9.4650 http://www.jimmunol.org/content/168/9/4650 Downloaded from References This article cites 49 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4650.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Profound Differences in Leukocyte-Endothelial Cell Responses to Lipopolysaccharide Versus Lipoteichoic Acid1 Bryan G. Yipp,* Graciela Andonegui,† Christopher J. Howlett,‡ Stephen M. Robbins,‡ Thomas Hartung,§ May Ho,* and Paul Kubes2† We have investigated the effects of LPS from Escherichia coli, lipoteichoic acid (LTA), and peptidoglycan (PepG) from Staphy- lococcus aureus, and live S.
    [Show full text]
  • Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19
    Version of 16.06.2020 Overview of planned or ongoing studies of drugs for the treatment of COVID-19 Table of contents Antiviral drugs ............................................................................................................................................................. 4 Remdesivir ......................................................................................................................................................... 4 Lopinavir + Ritonavir (Kaletra) ........................................................................................................................... 7 Favipiravir (Avigan) .......................................................................................................................................... 14 Darunavir + cobicistat or ritonavir ................................................................................................................... 18 Umifenovir (Arbidol) ........................................................................................................................................ 19 Other antiviral drugs ........................................................................................................................................ 20 Antineoplastic and immunomodulating agents ....................................................................................................... 24 Convalescent Plasma ...........................................................................................................................................
    [Show full text]
  • Myosin Contraction During Apoptosis Release Damage-Associated Molecular Pattern Proteins Before Secondary Necrosis Occurs
    Cell Death and Differentiation (2013) 20, 1293–1305 OPEN & 2013 Macmillan Publishers Limited All rights reserved 1350-9047/13 www.nature.com/cdd Blebs produced by actin–myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs GR Wickman1,2 3, L Julian1,2, K Mardilovich1, S Schumacher1, J Munro1, N Rath1, SAL Zander1, A Mleczak1, D Sumpton1, N Morrice1, WV Bienvenut1,4 and MF Olson*,1 Apoptosis is a fundamental homeostatic mechanism essential for the normal growth, development and maintenance of every tissue and organ. Dying cells have been defined as apoptotic by distinguishing features, including cell contraction, nuclear fragmentation, blebbing, apoptotic body formation and maintenance of intact cellular membranes to prevent massive protein release and consequent inflammation. We now show that during early apoptosis limited membrane permeabilization occurs in blebs and apoptotic bodies, which allows release of proteins that may affect the proximal microenvironment before the catastrophic loss of membrane integrity during secondary necrosis. Blebbing, apoptotic body formation and protein release during early apoptosis are dependent on ROCK and myosin ATPase activity to drive actomyosin contraction. We identified 231 proteins released from actomyosin contraction-dependent blebs and apoptotic bodies by adapted SILAC (stable isotope labeling with amino acids in cell culture) combined with mass spectrometry analysis. The most enriched proteins released were the nucleosomal histones, which have previously been identified as damage-associated molecular pattern proteins (DAMPs) that can initiate sterile inflammatory responses. These results indicate that limited membrane permeabilization occurs in blebs and apoptotic bodies before secondary necrosis, leading to acute and localized release of immunomodulatory proteins during the early phase of active apoptotic membrane blebbing.
    [Show full text]